Legato Capital Management »

Eton Pharmaceuticals shares owned by Legato Capital Management

Quarter-by-quarter ownership of Eton Pharmaceuticals (ETON) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Eton Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eton Pharmaceuticals held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eton Pharmaceuticals by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $417k 12k 36.20

More positions owned by Legato Capital Management

Argan (AGX)
Stonex Group (SNEX)
Ies Hldgs (IESC)
Agilysys (AGYS)
VSE Corporation (VSEC)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
LSI Industries (LYTS)
Apple (AAPL)
Triumph Ban (TFIN)
UFP Technologies (UFPT)
Lincoln Educational Services Corporation (LINC)
Bgc Group Inc Cl A (BGC)
Modine Manufacturing (MOD)
Microsoft Corporation (MSFT)

View all positions for Legato Capital Management

Top funds holding Eton Pharmaceuticals

Opaleye Management
EcoR1 Capital
BlackRock
Nantahala Capital Management
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Oberweis Asset Management
National Philanthropic Trust
Morgan Stanley
Westside Investment Management
Nuveen
Bnp Paribas Arbitrage, Snc
Woodline Partners
Thompson, Siegel, & Walmsley

View all funds holding Eton Pharmaceuticals